Lindsey Carr

Findings from a study in JAMA Network Open reveal valuable insight into the way cannabis legalization has impacted the perceptions of pregnant women who use cannabis in the US.

The FDA has approved another Tdap vaccine option for use during pregnancy to prevent pertussis, otherwise known as whooping cough.

Results from a randomized controlled trial study suggest dextromethorphan may even worsen patient pain experience.

More women are using medical cannabis for menopause-related symptoms.

What we know about monkeypox in pregnancy, including treatment recommendations, vaccination, and postpartum care.

Oteseconazole treats recurrent vulvovaginal candidiasis in women without reproductive potential.

The Department of Health and Human Services (HHS) launched a website Friday which offers women a comprehensive list of reproductive health care resources, services, and information.

A presentation at the Society for Maternal-Fetal Medicine’s (SMFM) 42nd Annual Pregnancy Meeting explored possible associations with marijuana use and nausea and vomiting in early pregnancy.

An oral concurrent session at SMFM’s 42nd Annual Pregnancy Meeting highlighted an analysis of pregnancy outcomes after optimal prenatal opioid use disorder care.

Agile Therapeutics, Inc. recently announced a new alliance with Afaxys Pharma, LLC to promote levonorgestrel and ethinyl estradiol (Twirla) transdermal system.

The drug is used to treat bacterial vaginosis and is a generic version of Bausch Health US LLC’s MetroGel-Vaginal.

Provider bias is often based on racial/ethnic, socioeconomic, and age-based assumptions.

According to new survey data from the National Foundation for Infectious Diseases, nearly 1 in 4 people at high risk for flu-related complications, such as pregnant women, did not plan to get vaccinated.

The Practice Advisory, developed by the American College of Obstetricians and Gynecologists (ACOG), offers an overview of the latest guidance for COVID-19 vaccination in pregnant and lactating patients.

Nextstellis (drospirenone; estetrol) now is approved as a combined oral contraceptive for birth control.